电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

RUNX2 抗体 (AA 219-404) (FITC)

This anti-RUNX2 antibody is a 兔 多克隆 antibody detecting RUNX2 in not_set. Suitable for 人.
产品编号 ABIN7168487
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for RUNX2 抗体 (AA 219-404) (FITC) (ABIN7168487)

抗原

See all RUNX2 抗体
RUNX2 (Runt-Related Transcription Factor 2 (RUNX2))

适用

  • 141
  • 66
  • 42
  • 10
  • 9
  • 8
  • 8
  • 8
  • 7
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1

宿主

  • 128
  • 18

克隆类型

  • 108
  • 38
多克隆

标记

  • 68
  • 9
  • 7
  • 7
  • 6
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
This RUNX2 antibody is conjugated to FITC

应用范围

请咨询
  • 抗原表位

    • 16
    • 16
    • 9
    • 8
    • 7
    • 6
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 219-404

    原理

    RUNX2 Antibody, FITC conjugated

    纯化方法

    Protein G purified

    纯度

    >95 %

    免疫原

    Recombinant Human Runt-related transcription factor 2 protein (219-404AA)

    亚型

    IgG
  • 限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    储存液

    ProClin

    注意事项

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C,-80 °C

    储存方法

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 抗原

    RUNX2 (Runt-Related Transcription Factor 2 (RUNX2))

    别名

    RUNX2

    背景

    Background: Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis. Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5\'-PYGPYGGT-3\', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I) collagen, LCK, IL-3 and GM-CSF promoters. In osteoblasts, supports transcription activation: synergizes with SPEN/MINT to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Inhibits KAT6B-dependent transcriptional activation.

    Aliases: Acute myeloid leukemia 3 protein antibody, Alpha subunit 1 antibody, AML3 antibody, CBF alpha 1 antibody, CBF-alpha-1 antibody, CBFA1 antibody, CCD antibody, CCD1 antibody, Cleidocranial dysplasia 1 antibody, Core binding factor antibody, Core binding factor runt domain alpha subunit 1 antibody, Core binding factor subunit alpha 1 antibody, Core-binding factor subunit alpha-1 antibody, MGC120022 antibody, MGC120023 antibody, Oncogene AML 3 antibody, Oncogene AML-3 antibody, OSF 2 antibody, OSF-2 antibody, OSF2 antibody, Osteoblast specific transcription factor 2 antibody, Osteoblast-specific transcription factor 2 antibody, OTTHUMP00000016533 antibody, PEA2 alpha A antibody, PEA2-alpha A antibody, PEA2aA antibody, PEBP2 alpha A antibody, PEBP2-alpha A antibody, PEBP2A1 antibody, PEBP2A2 antibody, PEBP2aA antibody, PEBP2aA1 antibody, Polyomavirus enhancer binding protein 2 alpha A subunit antibody, Polyomavirus enhancer-binding protein 2 alpha A subunit antibody, Runt domain antibody, Runt related transcription factor 2 antibody, Runt-related transcription factor 2 antibody, RUNX2 antibody, RUNX2_HUMAN antibody, SL3 3 enhancer factor 1 alpha A subunit antibody, SL3-3 enhancer factor 1 alpha A subunit antibody, SL3/AKV core binding factor alpha A subunit antibody, SL3/AKV core-binding factor alpha A subunit antibody

    UniProt

    Q13950
You are here: